IL-1β scavenging by the type IIIL-1 decoy receptor in human neutrophils

被引:84
|
作者
Bourke, E
Cassetti, A
Villa, A
Fadlon, E
Colotta, F
Mantovani, A
机构
[1] Univ Milan, Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
[2] Univ Milan, Consorzio MIA Dipartimento Neurosci, Milan, Italy
[3] Univ Milan, Ctr IDET, Ist Patol Gen, Milan, Italy
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 170卷 / 12期
关键词
D O I
10.4049/jimmunol.170.12.5999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 elicits its cellular effects by binding a heterodimeric receptor consisting of IL-1RI and the accessory protein, IL-1RAcPr. In addition, it binds to IL-1RII, which lacking signaling function has been ascribed a decoy role. The fate of the ligand following interaction with the decoy receptor was examined in human polymorphonuclear cells (PMN), which express predominantly (>90%) IL-1RII. Incubation of PMN with IL-1beta results in a rapid decrease in cell surface-associated ligand accompanied by a concomitant increase in internalized IL-1 with 50-60% of IL-1beta located intracellularly within 1 h at 37degreesC. The use of blocking Abs revealed that IL-1 internalization is mediated exclusively by the decoy receptor. The results of inhibitor analysis demonstrate that internalization requires ATP synthesis and involves clathrin-mediated endocytos,is. Following removal of the ligand, the receptor was rapidly re-expressed on the cell surface. Cyclohexamide, a protein synthesis inhibitor, had no effect upon the process, suggesting that the re-expressed receptor was recycled. In addition, human keratinocytes stably transfected with IL-1RII (HaCAT 811) also internalized the IL-1RII with 43% cell surface receptor internalized after 90 min. Immunofluorescence microscopy revealed colocalization of the internalized receptor with wheat germ agglutinin-labeled internalized glycoproteins and early endosome Ag-1, a protein associated with the early endosome compartments, indicative of cellular uptake of IL-1RII by endocytosis. In contrast, little or no internalization was observed in other cells of immune origin. These results suggest that the decoy receptor IL-1RII can act as a scavenger of IL-1, representing a novel autoregulatory mechanism of the IL-1 system.
引用
收藏
页码:5999 / 6005
页数:7
相关论文
共 50 条
  • [21] Soluble IL-1 decoy receptor is associated with gastric adenocarcinoma
    Cakir, Isil
    Kilic, Eser
    Coskun, Banu Demet Ozel
    Cakir, Nuri
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (05): : 545 - 549
  • [22] The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation - Preponderance of IL-1Ra detection
    Roberge, CJ
    Poubelle, PE
    Beaulieu, AD
    Heitz, D
    Gosselin, J
    JOURNAL OF IMMUNOLOGY, 1996, 156 (12): : 4884 - 4891
  • [23] Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II
    Ruggiero, P
    Bossu, P
    Macchia, G
    DelGrosso, E
    Sabbatini, V
    Bertini, R
    Colagrande, A
    Bizzarri, C
    Maurizi, G
    DiCioccio, V
    DAndrea, G
    DiGiulio, A
    Frigerio, F
    Grifantini, R
    Grandi, G
    Tagliabue, A
    Boraschi, D
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3881 - 3887
  • [24] Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding
    Cui, XL
    Rouhani, FN
    Hawari, F
    Levine, SJ
    JOURNAL OF IMMUNOLOGY, 2003, 171 (12): : 6814 - 6819
  • [25] The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type IIL-1 receptor
    Irikura, VM
    Lagraoui, M
    Hirsh, D
    JOURNAL OF IMMUNOLOGY, 2002, 169 (01): : 393 - 398
  • [26] Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation
    Palmer, Gaby
    Talabot-Ayer, Dominique
    Kaya, Guerkan
    Gabay, Cem
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) : 1938 - 1946
  • [27] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [28] Type-II IL-1β decoy receptor:: Potential for gene therapy in arthritis.
    Amin, AR
    Attur, MG
    Dave, MN
    Cipolletta, C
    Woo, SLC
    Meseck, M
    Abramson, SB
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S99 - S99
  • [29] EFFECTS OF PERIODONTOPATHIC BACTERIA ON IL-1 AND IL-1 INHIBITOR PRODUCTION BY HUMAN POLYMORPHONUCLEAR NEUTROPHILS
    YAMAZAKI, K
    POLAK, B
    BIRD, PS
    GEMMELL, E
    HARA, K
    SEYMOUR, GJ
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 1989, 4 (04): : 193 - 198
  • [30] The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis
    Bessis, N
    Guéry, L
    Mantovani, A
    Vecchi, A
    Sims, JE
    Fradelizi, D
    Boissier, MC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (03) : 867 - 875